Explore Watchlists Pricing

HISAMITSU PHARMACEUTICAL CO.,INC. (E00944) Income statement

Market cap

P/E ratio

Hisamitsu Pharmaceutical manufactures and sells over-the-counter medications like allergy treatments, operating globally through subsidiaries in the US, Europe, and Asia.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/02	2013/02	2014/02	2015/02	2016/02	2017/02	2018/02	2019/02	2020/02	2021/02	2022/02	2023/02	2024/02	2025/02	2026/02
Revenue	137,794	142,772	150,635	156,743	161,852	145,925	147,870	143,408	140,992	114,510	120,193	128,330	141,706	156,006	163,024
Revenue growth (%)	-
Cost of revenue	-	-	-	57,063	58,319	53,155	55,688	54,727	53,388	45,337	50,126	55,630	62,735	64,810	66,903
Gross profit	-	-	-	99,680	103,532	92,770	92,182	88,680	87,603	69,173	70,067	72,699	78,970	91,196	96,121
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating expenses	-	-	-	79,153	75,802	66,464	65,836	66,401	64,875	58,501	60,730	61,099	65,803	72,300	78,203
Operating income	-	-	-	20,527	27,730	26,306	26,345	22,278	22,727	10,671	9,337	11,599	13,167	18,895	17,917
Income before tax	33,494	33,051	28,910	28,489	28,008	28,179	28,245	24,647	25,628	11,829	12,638	16,051	19,649	24,010	23,952
Pretax margin (%)	24.3	23.1	19.2	18.2	17.3	19.3	19.1	17.2	18.2	10.3	10.5	12.5	13.9	15.4	14.7
Provision for income taxes	-	-	-	10,431	9,993	9,443	8,367	6,294	7,244	2,764	3,093	3,987	4,754	6,385	4,104
Effective tax rate (%)	-	-	-
Net income	18,439	18,809	21,357	18,784	17,784	20,541	19,327	19,378	18,911	9,433	9,862	12,126	14,431	22,301	9,246
Earnings per share	215.09	219.56	249.3	219.28	208.81	241.27	228.52	230.08	227.58	113.22	118.92	148.01	181.62	295.57	268.56
Diluted EPS	-	-	-	-	208.76	241.15	228.35	229.86	227.3	113.11	118.84	147.88	181.42	295.15	-
Dividend payout ratio (%)	-	-	-	-	-	-	-	-							-
Dividend per share	-	-	-	-	-	-	-	-	83	83.5	84	84.5	85	90	60